Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An fMRI Investigation of the Effects of Selective Histamine-3 Receptor Antagonism on Cognitive and Emotional Processing in Healthy Individuals

NCT05849675 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05849675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05849675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An fMRI Investigation of the Effects of Selective Histamine-3 Receptor Antagonism on Cognitive and Emotional Processing in Healthy Individuals
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2023
Completion date
May 8, 2024
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, cognitive function